Hospital Pharmacy - May 2017 - 372

372
benefits in one type of procedure may not predict success in
other patients. This study adds to the knowledge regarding
the value of liposomal bupivacaine use for orthopedic hip
procedures from a rehabilitation perspective by examining
the effect on distance ambulation. There were no significant
improvements in distance of ambulation on most days; however, there was an unexplained significant increase on day 2.
Previous studies have not examined physical therapy milestones so further studies in randomized controlled designs
are warranted on any potential benefits.
No significant differences in either knee or hip patients
were noted with respect to adverse events, except as related
to nausea. The validity of these findings may be limited,
because documentation of adverse events in the electronic
medical chart had significant missing data. The decreased
need for opioid medications is beneficial in improving participation in physical therapy as patients can focus on
advanced skills, such as stair climbing, needed for discharge.
Increased opioid use can contribute to decreased safety
awareness and unnecessary falls.35 While the shorter length
of hospitalization may have minimal direct economic implications, there is a potential benefit in decreasing the risk of
infection and thromboembolism from the hospital environment. Further studies are warranted to quantify the potential
health economic benefits in this setting.
There are a number of limitations for this study including
the retrospective study design, comparison to a historical
cohort group, and significant missing data for adverse events.
Having all patients seen by a single surgeon would theoretically limit any bias or confounding related to surgical technique. Multivariate regression analysis to minimize any
effects of confounding variables adds rigor to the analysis.

Conclusion
The use of intraoperative liposomal bupivacaine was beneficial during orthopedic knee procedures in producing a relatively modest reduction in concurrent postoperative opioid
analgesic medication; however, similar results were not seen
in patients having orthopedic hip procedures. Both groups of
patients experienced a delay in first opioid rescue pain medication but no clinically significant improvement in overall
pain management during the 72-hour postoperative period.
Differences in ambulation between groups were limited.
These findings suggest a limited role for liposomal bupivacaine in achieving positive health outcomes for patients
undergoing orthopedic knee or hip procedures.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect
to the research, authorship, and/or publication of this article.

Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.

Hospital Pharmacy 52(5)
References
1. National Hospital Discharge Survey. 2010 table, procedures by selected patient characteristics-number by procedure category and age. Hyattsville, MD: Centers for Disease
Control and Prevention. https://www.cdc.gov/nchs/data/
nhds/4procedures/2010pro4_numberprocedureage.pdf.
Published 2010. Accessed June 7, 2017.
2. Weinstetin AM, Rome BN, Reichmann WM, et al. Estimating
the burden of total knee replacement in the united states. J
Bone Joint Surg Am. 2013;95(5):385-392.
3. Bohensky M, Ackerman I, de Steiger R, Gorelik A, Brand
C. Lifetime risk of total hip replacement surgery and temporal trends in utilization: a population-based analysis. Arthritis
Care Res. 2014;66(8):1213-1219.
4. Culliford DJ, Maskell J, Kiran A, et al. The lifetime risk of total
hip and knee arthroplasty: results from the UK general practice
research database. Osteoarthritis Cartilage. 2012;20(6):519-524.
5. Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative
pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg.
2003;97(2):534-540.
6. Warfield CA, Kahn CH. Acute pain management. Programs
in U.S. hospitals and experiences and attitudes among U.S.
adults. Anesthesiology. 1995;83(5):1090-1094.
7. American Society of Anesthesiologists Task Force on Acute
Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the
American Society of Anesthesiologists Task Force on Acute
Pain Management. Anesthesiology. 2012;116(2):248-273.
8. Parvizi J, Bloomfield MR. Multimodal pain management
in orthopedics: implications for joint arthroplasty surgery.
Orthopedics. 2013;36(suppl 2):7-14.
9. Barrington JW, Halaszynski TM, Sinatra RS; Expert Working
Group on Anesthesia and Orthopaedics Critical Issues in Hip
And Knee Replacement Arthroplasty FT. Perioperative pain
management in hip and knee replacement surgery. Am J Orthop
(Belle Mead NJ). 2014;43(suppl 4):S1-S16.
10. Lovich-Sapola J, Smith CE, Brandt CP. Postoperative pain
control. Surg Clin North Am. 2015;95(2):301-318.
11. Kelly JS, Opsha Y, Costello J, Schiller D, Hola ET. Opioid
use in knee arthroplasty after receiving intravenous acetaminophen. Pharmacotherapy. 2014;34(suppl 1):22S-26S.
12. Lamplot JD, Wagner ER, Manning DW. Multimodal pain
management in total knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty. 2014;29(2):329-334.
13. Kang H, Ha Y-C, Kim J-Y, Woo Y-C, Lee J-S, Jang E-C.
Effectiveness of multimodal pain management after bipolar hemiarthroplasty for hip fracture. J Bone Joint Surg Am.
2013;95(4):291-296.
14. Parvataneni HK, Shah VP, Howard H, Cole N, Ranawat AS,
Ranawat CS. Controlling pain after total hip and knee arthroplasty using a multimodal protocol with local periarticular
injections: a prospective randomized study. J Arthroplasty.
2007;22(suppl 6):33-38.
15. Exparel (liposomal bupivacaine) [package insert]. San Diego,
CA: Pacira Pharmaceuticals, Inc; 2015.
16. Skolnik A, Gan TJ. New formulations of bupivacaine for
the treatment of postoperative pain: liposomal bupivacaine
and SABER-bupivacaine. Expert Opin Pharmacother.
2014;15(11):1535-1542.


https://www.cdc.gov/nchs/data/nhds/4procedures/2010pro4_numberprocedureage.pdf https://www.cdc.gov/nchs/data/nhds/4procedures/2010pro4_numberprocedureage.pdf

Table of Contents for the Digital Edition of Hospital Pharmacy - May 2017

Editorial, For Sale: FDA Priority Review Vouchers
Current FDA-Related Drug Information; Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings
ISMP Adverse Drug Reactions: Levofloxacin-Induced Neuroexcitation and Hallucinations Statin-Induced Muscle Rupture Mefloquine-Induced Rhabdomyolysis Methimazole-Induced
Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy
Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer
Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients
Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention
Pharmacists’ Knowledge of the Cost of Laboratory Testing
Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers
Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital
Formulary Drug Reviews
Hospital Pharmacy - May 2017 - 317
Hospital Pharmacy - May 2017 - 318
Hospital Pharmacy - May 2017 - 319
Hospital Pharmacy - May 2017 - 320
Hospital Pharmacy - May 2017 - 321
Hospital Pharmacy - May 2017 - 322
Hospital Pharmacy - May 2017 - 323
Hospital Pharmacy - May 2017 - Editorial, For Sale: FDA Priority Review Vouchers
Hospital Pharmacy - May 2017 - 325
Hospital Pharmacy - May 2017 - Current FDA-Related Drug Information; Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Hospital Pharmacy - May 2017 - Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings
Hospital Pharmacy - May 2017 - 328
Hospital Pharmacy - May 2017 - 329
Hospital Pharmacy - May 2017 - ISMP Adverse Drug Reactions: Levofloxacin-Induced Neuroexcitation and Hallucinations Statin-Induced Muscle Rupture Mefloquine-Induced Rhabdomyolysis Methimazole-Induced
Hospital Pharmacy - May 2017 - 331
Hospital Pharmacy - May 2017 - 332
Hospital Pharmacy - May 2017 - 333
Hospital Pharmacy - May 2017 - Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy
Hospital Pharmacy - May 2017 - 335
Hospital Pharmacy - May 2017 - 336
Hospital Pharmacy - May 2017 - 337
Hospital Pharmacy - May 2017 - 338
Hospital Pharmacy - May 2017 - 339
Hospital Pharmacy - May 2017 - 340
Hospital Pharmacy - May 2017 - Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer
Hospital Pharmacy - May 2017 - 342
Hospital Pharmacy - May 2017 - 343
Hospital Pharmacy - May 2017 - 344
Hospital Pharmacy - May 2017 - 345
Hospital Pharmacy - May 2017 - 346
Hospital Pharmacy - May 2017 - 347
Hospital Pharmacy - May 2017 - Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients
Hospital Pharmacy - May 2017 - 349
Hospital Pharmacy - May 2017 - 350
Hospital Pharmacy - May 2017 - 351
Hospital Pharmacy - May 2017 - 352
Hospital Pharmacy - May 2017 - Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention
Hospital Pharmacy - May 2017 - 354
Hospital Pharmacy - May 2017 - 355
Hospital Pharmacy - May 2017 - 356
Hospital Pharmacy - May 2017 - Pharmacists’ Knowledge of the Cost of Laboratory Testing
Hospital Pharmacy - May 2017 - 358
Hospital Pharmacy - May 2017 - 359
Hospital Pharmacy - May 2017 - 360
Hospital Pharmacy - May 2017 - Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers
Hospital Pharmacy - May 2017 - 362
Hospital Pharmacy - May 2017 - 363
Hospital Pharmacy - May 2017 - 364
Hospital Pharmacy - May 2017 - 365
Hospital Pharmacy - May 2017 - 366
Hospital Pharmacy - May 2017 - Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital
Hospital Pharmacy - May 2017 - 368
Hospital Pharmacy - May 2017 - 369
Hospital Pharmacy - May 2017 - 370
Hospital Pharmacy - May 2017 - 371
Hospital Pharmacy - May 2017 - 372
Hospital Pharmacy - May 2017 - 373
Hospital Pharmacy - May 2017 - Formulary Drug Reviews
Hospital Pharmacy - May 2017 - 375
Hospital Pharmacy - May 2017 - 376
Hospital Pharmacy - May 2017 - 377
Hospital Pharmacy - May 2017 - 378
Hospital Pharmacy - May 2017 - 379
Hospital Pharmacy - May 2017 - 380
Hospital Pharmacy - May 2017 - 381
Hospital Pharmacy - May 2017 - 382
Hospital Pharmacy - May 2017 - 383
Hospital Pharmacy - May 2017 - 384
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2019
http://www.nxtbook.com/nxtbooks/sage/fai_201909
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_july2019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2019
http://www.nxtbook.com/nxtbooks/sage/canadianpharmacistsjournal_05062019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2019
http://www.nxtbook.com/nxtbooks/sage/sri_supplement_201903
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2018
http://www.nxtbook.com/nxtbooks/sage/tec_20180810
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2018
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2018
http://www.nxtbook.com/nxtbooks/sage/fai_201807
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2018
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2018
http://www.nxtbook.com/nxtbooks/sage/sri_supplement_201803
http://www.nxtbook.com/nxtbooks/sage/slas_discovery_201712
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2018
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_november2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_september2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2017
http://www.nxtbook.com/nxtbooks/sage/fai_supplement_201709
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_may2017
http://www.nxtbook.com/nxtbooks/sage/fai_201706
http://www.nxtbook.com/nxtbooks/sage/fai_201607
http://www.nxtbookMEDIA.com